#
Levbid ER Tablets
  • Professionals
  • FDA PI

Levbid ER Tablets

Generic name: hyoscyamine sulfate
Dosage form: tablet, extended release
Drug class:Anticholinergics / antispasmodics

Medically reviewed by Drugs.com. Last updated on Jun 21, 2021.

Disclaimer: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. For further information about unapproved drugs, click here.

DESCRIPTION:

Levbid® extended-release tablets contain 0.375 mg of hyoscyamine sulfate in a formulation designed for oral b.i.d. dosage.

Hyoscyamine sulfate is one of the principal anticholinergic/ antispasmodic components of belladonna alkaloids. The empirical formula is (C17H23NO3)2•H2SO4•2H2O and the molecular weight is 712.85. Chemically, it is benzeneacetic acid, α-(hydroxymethyl)-, 8-methyl-8-azabicyclo [3.2.1.] oct-3-yl ester, [3(S)-endo]-, sulfate (2:1), dihydrate with the following structure:

LEARN MORE ABOUT US
CONTACT INFORMATION

LINKS

MEDICAL DEPARTMENTS

Cardiology
Pediatrics
Diabetes Care
Pre-natal Care
Ultrasound Echocardiogram